• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550350-15
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 06/18/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device was returned.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that the procedure was to treat a mildly calcified lesion in right coronary artery.A 3.5x15mm xience sierra stent delivery system (sds) was prepared per the instructions for use.The stent was successfully deployed at 12 atmospheres without any issues, the sds was moved to post dilate the edge of the stent as per standard procedure.An attempt was made to inflate the balloon of the sds; however, pressure did not increase and no inflation was made.The procedure was successfully completed with the deployment of an unspecified 4.0 mm stent due to the lesion length and post-dilatation of both stents was performed with the sds balloon of the second stent.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
A visual and functional inspections were performed on the returned sds.The reported balloon rupture was unable to be confirmed as the balloon was able to inflate without any rupture noted.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints reported from this lot.The investigation determined the reported balloon rupture appears to be related to operational circumstances of the procedure.In this case, based on the returned analysis, it is likely that during repositioning of the sds the outer member tore against other devices used causing the device to leak and what was believed was a balloon rupture.The noted bends on the hypotube likely occurred during packing for return analysis.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10261046
Report Number2024168-2020-05686
Device Sequence Number19697539
Product Code NIQ
UDI-Device Identifier08717648227417
UDI-Public08717648227417
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source company representative,distri
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/09/2021
Device Model Number1550350-15
Device Catalogue Number1550350-15
Device Lot Number809034A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/08/2020
Initial Date Received by Manufacturer 06/19/2020
Supplement Date Received by Manufacturer07/30/2020
Initial Report FDA Received Date07/10/2020
Supplement Report FDA Received Date07/31/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-